This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, J.
Right arrow Articles by Frazer, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, J.
Right arrow Articles by Frazer, I.

 Previous Article  |  Next Article 

Journal of Virology, June 1999, p. 4972-4982, Vol. 73, No. 6
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Papillomavirus Capsid Protein Expression Level Depends on the Match between Codon Usage and tRNA Availability

Jian Zhou,dagger Wen Jun Liu, Shi Wen Peng, Xiao Yi Sun, and Ian Frazer*

Centre for Immunology & Cancer Research, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia

Received 25 November 1998/Accepted 11 February 1999

Translation of mRNA encoding the L1 and L2 capsid proteins of papillomavirus (PV) is restricted in vivo to differentiated epithelial cells, although transcription of the L1 and L2 late genes occurs more widely. The codon composition of PV late genes is quite different from that of most mammalian genes. To test the possibility that PV late gene codon composition determines the efficiency of PV late gene expression in some cell types, synthetic bovine papillomavirus type 1 (BPV1) late genes were constructed with codon composition modified to resemble the typical mammalian gene. Expression of these genes from a strong promoter in Cos-1 cells was compared with expression of wild-type BPV1 late genes from the same promoter. Both unmodified and modified PV late genes were transcribed in Cos-1 cells, but only the codon-modified genes were translated. In vitro translation of wild-type but not synthetic BPV1 L1 mRNA was markedly enhanced by addition of aminoacyl-tRNAs. Codon composition thus limits BPV1 late gene translation in Cos-1 cells, and this limitation can be overcome by modification of the codon composition of the genes or by provision of excess tRNA. Replacement of codons in the green fluorescent protein (gfp) gene with those frequently used in PV late genes did not alter gfp transcription in Cos-1 cells but almost abolished translation, supporting the hypothesis that the observed differences in efficiency of translation of modified and unmodified PV capsid genes were related to codon usage rather than mRNA structure. As tRNA populations vary within and between tissues in the same eukaryotic organism, we speculate that matching of tRNA availability to codon usage may be one determinant of the restriction of expression of PV late genes to differentiated epithelium.


* Corresponding author. Mailing address: Centre for Immunology & Cancer Research, University of Queensland, Princess Alexandra Hospital, Brisbane QLD 4102, Australia. Phone: 61-7-3240 5315. Fax: 61-7-3240 2048. E-mail: ifrazer{at}medicine.pa.uq.edu.au.

dagger Jian Zhou passed away in Hangzhou, China, on 10 March 1999 after a brief illness. He is greatly missed.


Journal of Virology, June 1999, p. 4972-4982, Vol. 73, No. 6
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Carter, J. J., Paulson, K. G., Wipf, G. C., Miranda, D., Madeleine, M. M., Johnson, L. G., Lemos, B. D., Lee, S., Warcola, A. H., Iyer, J. G., Nghiem, P., Galloway, D. A. (2009). Association of Merkel Cell Polyomavirus-Specific Antibodies With Merkel Cell Carcinoma. JNCI J Natl Cancer Inst 101: 1510-1522 [Abstract] [Full Text]  
  • Sastalla, I., Chim, K., Cheung, G. Y. C., Pomerantsev, A. P., Leppla, S. H. (2009). Codon-Optimized Fluorescent Proteins Designed for Expression in Low-GC Gram-Positive Bacteria. Appl. Environ. Microbiol. 75: 2099-2110 [Abstract] [Full Text]  
  • Gu, W., Ding, J., Wang, X., de Kluyver, R. L., Saunders, N. A., Frazer, I. H., Zhao, K.-N. (2007). Generalized substitution of isoencoding codons shortens the duration of papillomavirus L1 protein expression in transiently gene-transfected keratinocytes due to cell differentiation. Nucleic Acids Res 0: gkm496v1-13 [Abstract] [Full Text]  
  • Gottschling, M., Stamatakis, A., Nindl, I., Stockfleth, E., Alonso, A., Bravo, I. G. (2007). Multiple Evolutionary Mechanisms Drive Papillomavirus Diversification. Mol Biol Evol 24: 1242-1258 [Abstract] [Full Text]  
  • Burns, C. C., Shaw, J., Campagnoli, R., Jorba, J., Vincent, A., Quay, J., Kew, O. (2006). Modulation of Poliovirus Replicative Fitness in HeLa Cells by Deoptimization of Synonymous Codon Usage in the Capsid Region. J. Virol. 80: 3259-3272 [Abstract] [Full Text]  
  • Zhao, K.-N., Gu, W., Fang, N. X., Saunders, N. A., Frazer, I. H. (2005). Gene Codon Composition Determines Differentiation-Dependent Expression of a Viral Capsid Gene in Keratinocytes In Vitro and In Vivo. Mol. Cell. Biol. 25: 8643-8655 [Abstract] [Full Text]  
  • Genther Williams, S. M., Disbrow, G. L., Schlegel, R., Lee, D., Threadgill, D. W., Lambert, P. F. (2005). Requirement of Epidermal Growth Factor Receptor for Hyperplasia Induced by E5, a High-Risk Human Papillomavirus Oncogene. Cancer Res. 65: 6534-6542 [Abstract] [Full Text]  
  • Pyeon, D., Lambert, P. F., Ahlquist, P. (2005). Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation. Proc. Natl. Acad. Sci. USA 102: 9311-9316 [Abstract] [Full Text]  
  • Bossis, I., Roden, R. B. S., Gambhira, R., Yang, R., Tagaya, M., Howley, P. M., Meneses, P. I. (2005). Interaction of tSNARE Syntaxin 18 with the Papillomavirus Minor Capsid Protein Mediates Infection. J. Virol. 79: 6723-6731 [Abstract] [Full Text]  
  • Buck, C. B., Thompson, C. D., Pang, Y.-Y. S., Lowy, D. R., Schiller, J. T. (2005). Maturation of Papillomavirus Capsids. J. Virol. 79: 2839-2846 [Abstract] [Full Text]  
  • Baud, D., Ponci, F., Bobst, M., De Grandi, P., Nardelli-Haefliger, D. (2004). Improved Efficiency of a Salmonella-Based Vaccine against Human Papillomavirus Type 16 Virus-Like Particles Achieved by Using a Codon-Optimized Version of L1. J. Virol. 78: 12901-12909 [Abstract] [Full Text]  
  • Gu, W., Li, M., Zhao, W. M., Fang, N. X., Bu, S., Frazer, I. H., Zhao, K.-N. (2004). tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes. Nucleic Acids Res 32: 4448-4461 [Abstract] [Full Text]  
  • Buck, C. B., Pastrana, D. V., Lowy, D. R., Schiller, J. T. (2004). Efficient Intracellular Assembly of Papillomaviral Vectors. J. Virol. 78: 751-757 [Abstract] [Full Text]  
  • Oberg, D., Collier, B., Zhao, X., Schwartz, S. (2003). Mutational Inactivation of Two Distinct Negative RNA Elements in the Human Papillomavirus Type 16 L2 Coding Region Induces Production of High Levels of L2 in Human Cells. J. Virol. 77: 11674-11684 [Abstract] [Full Text]  
  • Urrutia, A. O., Hurst, L. D. (2003). The Signature of Selection Mediated by Expression on Human Genes. Genome Res 13: 2260-2264 [Abstract] [Full Text]  
  • Biemelt, S., Sonnewald, U., Galmbacher, P., Willmitzer, L., Muller, M. (2003). Production of Human Papillomavirus Type 16 Virus-Like Particles in Transgenic Plants. J. Virol. 77: 9211-9220 [Abstract] [Full Text]  
  • Cid-Arregui, A., Juarez, V., Hausen, H. z. (2003). A Synthetic E7 Gene of Human Papillomavirus Type 16 That Yields Enhanced Expression of the Protein in Mammalian Cells and Is Useful for DNA Immunization Studies. J. Virol. 77: 4928-4937 [Abstract] [Full Text]  
  • Reuter, J. D., Vivas-Gonzalez, B. E., Gomez, D., Wilson, J. H., Brandsma, J. L., Greenstone, H. L., Rose, J. K., Roberts, A. (2002). Intranasal Vaccination with a Recombinant Vesicular Stomatitis Virus Expressing Cottontail Rabbit Papillomavirus L1 Protein Provides Complete Protection against Papillomavirus-Induced Disease. J. Virol. 76: 8900-8909 [Abstract] [Full Text]  
  • Zhao, K.-N., Frazer, I. H. (2002). Replication of Bovine Papillomavirus Type 1 (BPV-1) DNA in Saccharomyces cerevisiae following Infection with BPV-1 Virions. J. Virol. 76: 3359-3364 [Abstract] [Full Text]  
  • Collier, B., Oberg, D., Zhao, X., Schwartz, S. (2002). Specific Inactivation of Inhibitory Sequences in the 5' End of the Human Papillomavirus Type 16 L1 Open Reading Frame Results in Production of High Levels of L1 Protein in Human Epithelial Cells. J. Virol. 76: 2739-2752 [Abstract] [Full Text]  
  • Urrutia, A. O., Hurst, L. D. (2001). Codon Usage Bias Covaries With Expression Breadth and the Rate of Synonymous Evolution in Humans, but This Is Not Evidence for Selection. Genetics 159: 1191-1199 [Abstract] [Full Text]  
  • Leder, C., Kleinschmidt, J. A., Wiethe, C., Muller, M. (2001). Enhancement of Capsid Gene Expression: Preparing the Human Papillomavirus Type 16 Major Structural Gene L1 for DNA Vaccination Purposes. J. Virol. 75: 9201-9209 [Abstract] [Full Text]  
  • Levin, D. B., Whittome, B. (2000). Codon usage in nucleopolyhedroviruses. J. Gen. Virol. 81: 2313-2325 [Abstract] [Full Text]  
  • Gavrilin, G. V., Cherkasova, E. A., Lipskaya, G. Y., Kew, O. M., Agol, V. I. (2000). Evolution of Circulating Wild Poliovirus and of Vaccine-Derived Poliovirus in an Immunodeficient Patient: a Unifying Model. J. Virol. 74: 7381-7390 [Abstract] [Full Text]  
  • Bible, J. M., Mant, C., Best, J. M., Kell, B., Starkey, W. G., Shanti Raju, K., Seed, P., Biswas, C., Muir, P., Banatvala, J. E., Cason, J. (2000). Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons. J. Gen. Virol. 81: 1517-1527 [Abstract] [Full Text]